Charles J. Casamento Joins Osteologix as Chief Executive Officer.SAN FRANCISCO San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden -- Osteologix, Inc. and Osteologix A/S today announced that Charles J. Casamento has joined the company as CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , President and Director. Chuck Casamento has a strong track record in the pharmaceutical and biotech industries having been CEO for Interneuron interneuron /in·ter·neu·ron/ (-noor´on) 1. a neuron between the primary sensory neuron and the final motoneuron. 2. and RiboGene, which later became Questcor Pharmaceuticals, both of which he took public, as well as holding executive positions in Sandoz, Roche, Johnson & Johnson, American Hospital Supply Corporation and Genzyme. Interneuron reached a peak valuation of $1.6 Billion based on a major pharmaceutical license agreement with American Home For the American mortgage lender, see . The American Home is a center of intercultural exchange located in Vladimir, Russia. The home is designed to model a typical American suburban home and its main focus is the ESL school that provides lessons for Russian students. Products and the submission to FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. of a major New Drug Application which was assembled during his tenure. Mr. Casamento holds an MBA MBA abbr. Master of Business Administration Noun 1. MBA - a master's degree in business Master in Business, Master in Business Administration and a B.Sc. (Pharm) and is a registered pharmacist. "We are pleased to have attracted the caliber of senior management and entrepreneurial skills that Chuck Casamento represents," says chairman of the board, Klaus Eldrup-Joergensen, MD. "His joining is an important addition to Osteologix and further validates the business opportunity that the company is pursuing." Christian Hansen Christian Marius Hansen (born September 24, 1891 - died June 13, 1961) was a Danish gymnast who competed in the 1908 Summer Olympics and in the 1912 Summer Olympics. He was part of the Danish team, which finished fourth in the gymnastics team event in 1908. , PhD, co-founder and member of the board of Osteologix, and partner at Nordic Biotech, which is the principle investor in and shareholder of Osteologix, adds, "From the inception, the company has focused on rapid entry into later stage development of drugs for treating diseases of bone and cartilage. Mr. Casamento's experience is expected to make a strong impact on the growth of the company, in terms of business development, financing and leadership." "I was intrigued by the lead compounds of Osteologix and the exceptional value that they can come to represent in the treatment of bone diseases, such as osteoporosis," says Chuck Casamento. "With my long background in building late stage biotech companies, combined with the anticipated effectiveness of the company's future products and the large market for diseases such as osteoporosis, I feel strongly about the commercial outlook of Osteologix." Chuck Casamento will be based in the Osteologix, Inc. offices in San Francisco, CA. About Osteologix A/S: (www.osteologix.com) Osteologix is a San Francisco and Copenhagen based company, focused on the pre-clinical and clinical development of pharmaceutical products for the treatment of bone diseases such as osteoporosis. The lead compound, NBS (National Bureau of Standards) See NIST. NBS - National Bureau of Standards: part of the US Department of Commerce, now NIST. 101, belongs to a new class of drugs for treatment of osteoporosis, and other bone and cartilage diseases. This class of drugs is expected to become a major treatment option based on substantial clinical data from multiple large studies performed on a worldwide basis. America, Asia & Australia: Osteologix, Inc. 425 Market Street, Suite 2230 San Francisco, CA 94105 USA Tel: +1 (415) 955-2726 Fax: +1 (415) 955-2727 Att: Charles J. Casamento, Chief Executive Officer, ccasamento@osteologix.com Europe & Africa: Osteologix A/S Fruebjergvej 3 DK-2100 Copenhagen 0 Denmark Tel: +45-39 17 97 30 Fax: +45-39 17 97 31 Att: Stephan Christgau, PhD, Chief Operating Officer, sc@nordicbone.dk About Nordic Biotech: (www.nordicbiotech.com) Nordic Biotech is a specialized biotech venture capital fund focusing primarily on the Nordic countries but also the rest of the EU. The investment focus is mainly early stage, but also spin-outs and restructurings. The team behind Nordic Biotech has extensive experience in biotech investment and has co-founded or invested in a series of biotech successes, such as Genmab A/S, Profound Pharma A/S, Biomarin, Inc., Zealand Pharma A/S and many others over the last decade. Our partners include Christian Hansen, Ph.D, co-founder of Nordic Biotech and former director at Novo Nordisk Wikipedia is not the place for advertisement or self-advertising. Novo Nordisk (, NYSE: NVO) manufactures and markets pharmaceutical products and services. Founded in Denmark in 1923, the company has since become a world leader in diabetes care with the broadest , Florian Schonharting, co-founder of Nordic Biotech and former head of health care investing at Bank Invest and Henrik Nilsson Henrik Nilson (born 15 February 1976 in Nyköping) is a Swedish flatwater canoer and reigning Olympic K-2 1000m kayak champion. Nilsson represented Sweden at the 1996 Olympics as a member of the K-4 1000m kayak crew which placed seventh in the final. , M.D., Ph.D., senior analyst at Nordic Biotech. Nordic Biotech is affiliated with a strong advisory board consisting of global pharmaceutical research and development executives. Nordic Biotech has a very well respected investor base, including H. Lundbeck A/S, Danish Growth Fund, Biotechnology Value Fund L.P., The European Investment Fund The European Investment Fund, established in 1994, is a European Union agency for the provision of finance to SMEs (small and medium-sized enterprises) headquartered in Brussels. It does not lend money to SMEs directly; rather it provides finance through private banks. , HBM HBM Human Body Model HBM Human Brain Mapping HBM Hottinger Baldwin Messtechnik GmbH (German company) HBM High Bone Mass HBM Hybrid Bilayer Membrane HBM Humming Bird Medal HBM Her/His Britannic Majesty Bioventures and Wallenberg Capital. Nordic Biotech is the majority shareholder of Osteologix A/S. Nordic Biotech 0stergade 5, 3.s. DK- 1100 Copenhagen K Denmark Tel: +45-70 20 12 63 Fax: +45-70 20 12 64 Att: Christian Hansen, PhD, Partner, ch@nordicbiotech.com |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion